← Evidence map

ArticleNature biotechnology2013

The regulatory landscape for actively personalized cancer immunotherapies.

Cedrik M Britten et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24104749